What to expect at the BD&L Summit

 

Unlock the potential of a deal through optimized business development activities and transactional excellence to drive a company's competitive position in today's marketplace.

With the ROI for pharma R&D dwindling in recent years, business development and partnering opportunities have become an attractive strategy to bolster fledgling product pipelines and de-risk the development of new products. In order to ensure that every potential for unlocking the value of a transaction has been realized, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, and structure a transaction.

The BD&L Summit for Life Sciences will provide an overview of the industry’s most recent trends, and will feature the proven strategies and insights of leaders from biotech, mid-sized, and large pharmaceutical companies on successfully managing business development, M&A, strategic alliance, and licensing activities.

 

 Who Attends

This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include:

Business Development

Mergers and Acquisitions

Licensing

Strategic Alliance/Alliance Management

Intellectual Property and Patent Counsel

Search and Evaluation

Due Diligence

External Innovation

Transactions

Portfolio Management

Scientific Assessment

General Counsel/Corporate Counsel

Legal and Regulatory Compliance

Regulatory Affairs

Research and Development

Clinical Medicine

Clinical Operations

Life Cycle Management

 

  
  Past Participants of BD&L Summit Include

Abbott

Acadia

Allergan

Amgen

Arcus Biosciences

Astellas

Bayer

BeiGene

BioMarin

Boehringer Ingelheim

Daiichi Sankyo

Eli Lilly

Genentech

Heron Therapeutics

Janssen

Kaleo Pharma

Mallinckrodt

Merck

Myovant Sciences

Samumed

Sanofi

Theravance BioPharma

Vertex